Patents by Inventor Barbara ROLFE

Barbara ROLFE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10933049
    Abstract: The present invention discloses the use of a complement 3a receptor (C3aR) antagonist and a mobilizer of hematopoietic stem cells and/or progenitor cells in methods and compositions for stimulating or enhancing the development, mobilization, proliferation and/or differentiation of a neutrophil-containing leukocyte population that inhibits growth and/or spread of a tumor and for treating or preventing a hyperproliferative cell disorder.
    Type: Grant
    Filed: June 1, 2016
    Date of Patent: March 2, 2021
    Assignee: The University of Queensland
    Inventors: Trent Woodruff, Barbara Rolfe
  • Publication number: 20180185328
    Abstract: The present invention discloses the use of a complement 3a receptor (C3aR) antagonist and a mobilizer of hematopoietic stem cells and/or progenitor cells in methods and compositions for stimulating or enhancing the development, mobilization, proliferation and/or differentiation of a neutrophil-containing leukocyte population that inhibits growth and/or spread of a tumor and for treating or preventing a hyperproliferative cell disorder.
    Type: Application
    Filed: June 1, 2016
    Publication date: July 5, 2018
    Inventors: Trent WOODRUFF, Barbara ROLFE